Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 7, 2019 | Human | Unknown | Flunixin Megl Topical Solution | Dizziness; Feeling sick; Taste alteration | Recovered/Normal |
| Mar 7, 2019 | Human | Unknown | Copper Naphthenate | Increased heart rate; Generalised itching; Nausea | Outcome Unknown |
| Mar 7, 2019 | Human | Unknown | Fluralaner Chew Tablets | Application site skin change NOS | Ongoing |
| Mar 7, 2019 | Human | Unknown | Florfenicol/Terbinafine Hydrochloride... | Burning sensation of eye; Eye irritation | Recovered/Normal |
| Mar 7, 2019 | Human | Unknown | Moxidectin | Eye irritation; Eye pain; Accidental exposure | Recovered/Normal |
| Mar 6, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Vision blurred | Recovered/Normal |
| Mar 5, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking | Ongoing |
| Mar 5, 2019 | Human | Unknown | Tulathromycin | Injection site bleeding | Outcome Unknown |
| Mar 5, 2019 | Human | Unknown | Maropitant Citrate | Dizzy on standing; Vertigo; Central nervous system depression | Outcome Unknown |
| Mar 4, 2019 | Human | Unknown | Ceftiofur Crystalline Free Acid | Skin irritation; Scar; Puncture wound; Vision blurred; Eye pain; Eye redness;... | Ongoing |
| Mar 3, 2019 | Human | Unknown | Vit E/ Selenite Inj Solution | Wound; Injection site pain | Ongoing |
| Mar 1, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Tubes, Leaking | Ongoing |
| Mar 1, 2019 | Human | Unknown | Maropitant Citrate | Injection site pain; Injection site numbness; Injection site bruising | Outcome Unknown |
| Mar 1, 2019 | Human | Unknown | Spinosad | Reddening of the skin; Itching | Ongoing |
| Feb 28, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use; Tub... | Ongoing |
| Feb 27, 2019 | Human | Unknown | Dexmedetomidine Hydrochloride | Injection site pain; Dizziness; Accidental exposure | Outcome Unknown |
| Feb 25, 2019 | Human | Unknown | Mirtazapine | Localised numbness (see also application site SOC); Cyanotic spots/blotchy skin | Recovered/Normal |
| Feb 22, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Dispenser, Abnormal; Tub... | Ongoing |
| Feb 21, 2019 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Eye irritation | Outcome Unknown |
| Feb 21, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin discolouration; Application site erythema | Ongoing |
| Feb 21, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use | Ongoing |
| Feb 19, 2019 | Human | Unknown | Polysulfated Glycosaminoglycan | Itchy rash | Outcome Unknown |
| Feb 19, 2019 | Human | Unknown | Tulathromycin | Injection site pain | Outcome Unknown |
| Feb 19, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Hives (see also 'Skin') | Outcome Unknown |
| Feb 18, 2019 | Human | Unknown | Eprinomectin | Flatulence; Diarrhoea; General pain (see other SOCs for specific pain); Heada... | Outcome Unknown |
| Feb 15, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Localised hair loss | Outcome Unknown |
| Feb 15, 2019 | Human | Unknown | Isoflurane | Vertigo; Nausea; Difficulty in thinking; Headache | Recovered/Normal |
| Feb 15, 2019 | Human | Unknown | Isoflurane | Mental confusion; Mental impairment NOS | Outcome Unknown |
| Feb 14, 2019 | Human | Unknown | Copper Naphthenate | Application site swelling; Application site paraesthesia | Outcome Unknown |
| Feb 14, 2019 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site reddening; Injection site bleeding | Outcome Unknown |
| Feb 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Dispenser, Abnormal; Tub... | Outcome Unknown |
| Feb 12, 2019 | Human | Unknown | Enrofloxacin | Injection site erythema; Tingling sensation | Recovered/Normal |
| Feb 12, 2019 | Human | Unknown | Maropitant Citrate | Vomiting | Outcome Unknown |
| Feb 11, 2019 | Human | Unknown | Mirtazapine | Erythema (for urticaria see Immune SOC) | Ongoing |
| Feb 11, 2019 | Human | Unknown | Device: Syringe | Accidental exposure; Injury associated with device | Outcome Unknown |
| Feb 8, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation; Eye redness | Recovered/Normal |
| Feb 6, 2019 | Human | Unknown | Phytosphingosine Salicyloyl | Application site erythema; Localised pain NOS (see other 'SOCs' for specific ... | Recovered/Normal |
| Feb 5, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Eye irritation; Accidental exposure | Outcome Unknown |
| Feb 5, 2019 | Human | Unknown | Doramectin | Injection site pain | Outcome Unknown |
| Feb 5, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use | Ongoing |
| Feb 4, 2019 | Human | Unknown | Insulin Injectable Vial | Injection site reaction NOS; Accidental exposure; No sign | Ongoing |
| Feb 4, 2019 | Human | Unknown | Grapiprant | Nervousness | Outcome Unknown |
| Feb 4, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Closure, Abnormal; Containers, Leaking; Dis... | Ongoing |
| Feb 2, 2019 | Human | Unknown | Nitenpyram | Light headedness; Nausea; Accidental exposure | Recovered/Normal |
| Feb 2, 2019 | Human | Unknown | Ceftiofur Crystalline Free Acid | Puncture wound; Injection site oedema | Recovered/Normal |
| Feb 1, 2019 | Human | Unknown | Trilostane | Localised pain NOS (see other 'SOCs' for specific pain) | Recovered/Normal |
| Feb 1, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Lacrimation; Eye irritation; Odor, Abnormal | Recovered/Normal |
| Jan 31, 2019 | Human | Unknown | Mirtazapine | Burning sensation (skin) | Outcome Unknown |
| Jan 29, 2019 | Human | Unknown | Tilmicosin | Injection site reddening; Accidental exposure | Ongoing |
| Jan 28, 2019 | Human | Unknown | Ivermectin | Injection site pain; Accidental exposure | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.